Oragenics announces $20M preferred stock offering; shares surge over 138%

* Oragenics (NYSE:OGEN [https://seekingalpha.com/symbol/OGEN]) entered a placement agreement to sell up to 800,000 shares of Series H convertible preferred stock and accompanying warrants.
* Each unit, consisting of one preferred stock share and one warrant, is priced at $25, with warrants exercisable at the same price.
* The preferred stock is convertible into common stock at $2.50/share.
* Gross proceeds from the offering are expected to be up to $20M.
* Closing is expected on or about July 2, 2025.
* Proceeds will support ONP-2 concussion clinical trials, R&D, repayment of a $3M bridge note, and general corporate purposes.
* OGEN shares surge over 138% premarket on Tuesday.
* Source: Press release [https://seekingalpha.com/pr/20153329-oragenics-inc-announces-pricing-of-public-offering-of-up-to-20-million-of-preferred-stock-and]

MORE ON ORAGENICS

* Seeking Alpha’s Quant Rating on Oragenics [https://seekingalpha.com/symbol/OGEN/ratings/quant-ratings]
* Historical earnings data for Oragenics [https://seekingalpha.com/symbol/OGEN/earnings]
* Financial information for Oragenics [https://seekingalpha.com/symbol/OGEN/income-statement]